BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35896375)

  • 1. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
    Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
    Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced osteomalacia: a case report.
    Aligail K; Dave JA; Ross IL
    J Med Case Rep; 2022 Jan; 16(1):22. PubMed ID: 35016725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity].
    Ovchinnikov AY; Khon EM; Bakotina AV; Miroshnichenko NA; Gronskaia SA; Belaya ZE
    Vestn Otorinolaringol; 2023; 88(6):91-96. PubMed ID: 38153899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
    Westerberg PA; Linde T; Ljunggren O
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypophosphataemia-inducing mesenchymal tumour in the foot.
    Bauer C; Brücker R; Bützberger S; Schmid C
    BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22778109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphaturic Mesenchymal Tumor.
    Benson JC; Trejo-Lopez JA; Nassiri AM; Eschbacher K; Link MJ; Driscoll CL; Tiegs RD; Sfeir J; DeLone DR
    AJNR Am J Neuroradiol; 2022 Jun; 43(6):817-822. PubMed ID: 35589138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteomalacia caused by tumors in facies cranii mimicking rheumatoid arthritis.
    Xian-Ling W; Jian-Ming B; Wen-Wen Z; Zhao-Hui L; Jing-Tao D; Ju-Ming L; Yi-Ming M
    Rheumatol Int; 2012 Aug; 32(8):2573-6. PubMed ID: 21789616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.
    Gore MO; Welch BJ; Geng W; Kabbani W; Maalouf NM; Zerwekh JE; Moe OW; Sakhaee K
    Kidney Int; 2009 Aug; 76(3):342-7. PubMed ID: 18668025
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
    Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burosumab in tumor-induced osteomalacia: A case report.
    Day AL; Gutiérrez OM; Guthrie BL; Saag KG
    Joint Bone Spine; 2020 Jan; 87(1):81-83. PubMed ID: 31382017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.
    Yang IM; Park YK; Hyun YJ; Kim DY; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
    Korean J Intern Med; 1997 Jan; 12(1):89-95. PubMed ID: 9159046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced osteomalacia: a case report.
    Romualdo-Silva DD; Silva BC; Caetano CV; Tibúrcio AM; Nunes MB; Chagas SA; Polito ET; Ferreira AR; Purisch S
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):378-82. PubMed ID: 19578602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.